• Citer

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials

par Jensen, Donald M.;Ouzan, Denis;Wright, Mark;Morano, Luis Enrique;Buynak, Robert;Bourlière, Marc;Hassanein, Tarek;Nishiguchi, Shuhei;Kao, Jia Horng;Omata, Masao;Paik, Seungwoon;Asselah, Tarik;Wong, David;Tam, Edward;Kaita, Kelly;Victor Feinman, S.;Stern, Jerry J.O.;Scherer, Joseph;Quinson, Anne Marie;Voss, Florian;Gallivan, John Paul;Böcher, Wulf Otto;Dieterich, Douglas;Ferenci, Peter;Foster, Graham Russell;Sulkowski, Mark;Zeuzem, Stefan;Mantry, Parvez;Yoshida, Ericmasao E.M.;Moreno, Christophe
Référence Annals of Hepatology, 15, 3, page (333-349)
Publication Publié, 2016-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials
Auteur:	Jensen, Donald M.; Ouzan, Denis; Wright, Mark; Morano, Luis Enrique; Buynak, Robert; Bourlière, Marc; Hassanein, Tarek; Nishiguchi, Shuhei; Kao, Jia Horng; Omata, Masao; Paik, Seungwoon; Asselah, Tarik; Wong, David; Tam, Edward; Kaita, Kelly; Victor Feinman, S.; Stern, Jerry J.O.; Scherer, Joseph; Quinson, Anne Marie; Voss, Florian; Gallivan, John Paul; Böcher, Wulf Otto; Dieterich, Douglas; Ferenci, Peter; Foster, Graham Russell; Sulkowski, Mark; Zeuzem, Stefan; Mantry, Parvez; Yoshida, Ericmasao E.M.; Moreno, Christophe
Informations sur la publication:	Annals of Hepatology, 15, 3, page (333-349)
Statut de publication:	Publié, 2016-05
Sujet CREF:	Gastro-entérologie
Mots-clés:	Direct-acting antiviral
	Hepatitis C
	SVR12
	Viral hepatitis
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1665-2681
	info:doi/10.5604/16652681.1198803
	info:scp/84963705855